CTT Pharmaceutical Holdings CEO Ryan Khouri acquires 3,000 common shares valued at $147

PUBT · 2d ago
CTT Pharmaceutical Holdings CEO Ryan Khouri acquires 3,000 common shares valued at $147
  • CTT Pharmaceutical Holdings reported CEO Ryan Khouri bought 3,000 CTTH shares in an open-market purchase.
  • The shares were bought at $0.05 each.
  • Khouri’s direct stake rose to 9,387,256 shares following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CTT Pharmaceutical Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001035422-26-000009), on September 02, 2026, and is solely responsible for the information contained therein.